Charles River Laboratories International (CRL) Price/OCF Ratio: History & Chart

Charles River Laboratories International, Inc.(CRL)

Medical - Diagnostics & Research · Wilmington, MA

$290.53-1.23 (-0.42%)

Delayed quote: Sep 3, 2026, 2:49 PM EDT

About Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc. operates as a contract research organization (CRO), providing essential preclinical services to the pharmaceutical and biotechnology industries. Its core business revolves around assisting clients with drug discovery, non-clinical development, and thorough safety testing, with its services extending globally across the United States, Europe, Canada, and the Asia Pacific region. The company organizes its diverse offerings into three principal segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. 1. Research Models and Services (RMS): This division is a key supplier of high-quality rodent research models, including specially bred strains of rats and mice for experimental purposes. It also offers a comprehensive array of support services to help clients effectively utilize these models in their research and for the screening of potential non-clinical drug candidates. These include providing genetically engineered models, insourcing solutions for facility management, and diagnostic services for research animals. 2. Discovery and Safety Assessment (DSA): The DSA segment plays a crucial role in advancing early-stage drug pipelines. It delivers early-phase and in vivo discovery services focused on identifying and validating new therapeutic targets, chemical compounds, and antibodies. The ultimate goal is to prepare promising non-clinical drug and therapeutic candidates for subsequent safety evaluations. Additionally, this segment provides an extensive range of safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism studies, and pharmacokinetics. 3. Manufacturing Solutions: This segment addresses critical quality control requirements by offering in vitro methods for both routine and rapid testing of the quality of sterile and non-sterile pharmaceuticals, as well as consumer products. It also serves as a vital provider of specialized biologics testing, which is often outsourced by pharmaceutical and biotechnology companies. Furthermore, the segment supplies avian vaccine services, including specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products, all essential for vaccine production. Beyond these specialized segments, Charles River also manages contract vivarium operations, providing crucial animal housing and care facilities for its biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Wilmington, MA

19,000 employees

www.criver.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Birgit Girshick

View full financials

CRL Price/OCF Ratio Metrics

PRICE/OCF RATIO

24.30

PRICE/OCF RATIO AVG TTM

12.83

PRICE/OCF RATIO AVG 3Y

13.54

PRICE/OCF RATIO AVG 5Y

15.26

PRICE/OCF RATIO AVG 10Y

15.63

PRICE/OCF RATIO AVG 15Y

14.11

PRICE/OCF RATIO AVG 20Y

13.82

CURRENT VS TTM AVG

+89.36%

CURRENT VS 3Y AVG

+79.49%

CURRENT VS 5Y AVG

+59.21%

CURRENT VS 10Y AVG

+55.51%

CURRENT VS 15Y AVG

+72.28%

CURRENT VS 20Y AVG

+75.89%

SECTOR MEDIAN · HEALTHCARE

16.42

median of 83 covered companies

CURRENT VS SECTOR MEDIAN

+47.99%

vs the sector median at left

NAME	MARKET CAP	PRICE/OCF RATIO	TTM	3Y	5Y
Charles River Laboratories International, Inc. (CRL)	$13.99B	24.30	12.83	13.54	15.26
The Cooper Companies, Inc. (COO)vs ›	$13.75B	14.27	16.87	24.66	24.72
Revvity, Inc. (RVTY)vs ›	$14.56B	23.27	19.64	69.35	51.09
Baxter International Inc. (BAX)vs ›	$13.17B	10.09	11.69	13.85	15.17
Exelixis, Inc. (EXEL)vs ›	$14.94B	12.84	14.47	17.62	17.41
Penumbra, Inc. (PEN)vs ›	$12.67B	45.98	52.86	92.97	188.65
Encompass Health Corporation (EHC)vs ›	$12.13B	9.99	9.77	10.05	9.05
Solventum Corporation (SOLV)vs ›	$16.01B	76.69	46.93	25.01	25.01
DaVita Inc. (DVA)vs ›	$11.62B	5.41	6.00	6.17	5.84
Medpace Holdings, Inc. (MEDP)vs ›	$16.44B	22.66	21.76	21.42	20.89

NAME

MARKET CAP

PRICE/OCF RATIO

TTM

Charles River Laboratories International, Inc. (CRL)

$13.99B

24.30

12.83

13.54

15.26

The Cooper Companies, Inc. (COO)vs ›

$13.75B

14.27

16.87

24.66

24.72

Revvity, Inc. (RVTY)vs ›

$14.56B

23.27

19.64

69.35

51.09

Baxter International Inc. (BAX)vs ›

$13.17B

10.09

11.69

13.85

15.17

Exelixis, Inc. (EXEL)vs ›

$14.94B

12.84

14.47

17.62

17.41

Penumbra, Inc. (PEN)vs ›

$12.67B

45.98

52.86

92.97

188.65

Encompass Health Corporation (EHC)vs ›

$12.13B

9.99

9.77

10.05

9.05

Solventum Corporation (SOLV)vs ›

$16.01B

76.69

46.93

25.01

DaVita Inc. (DVA)vs ›

$11.62B

5.41

6.00

6.17

5.84

Medpace Holdings, Inc. (MEDP)vs ›

$16.44B

22.66

21.76

21.42

20.89

Price/OCF Ratio Formula & Definition

P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.

Price/OCF Ratio FAQ

What is the Price/OCF ratio for Charles River Laboratories International, Inc. (CRL)?

The Price/OCF ratio for CRL stock is 24.30.

Is Charles River Laboratories International, Inc.'s Price/OCF ratio high or low?

The Price/OCF ratio of 24.30 is 59% above its 5-year average of 15.26, around the middle of its 5-year range (6.94–34.98).

What is the TTM average Price/OCF ratio for Charles River Laboratories International, Inc. (CRL)?

The TTM average Price/OCF ratio for CRL stock is 12.83.

What is the 3Y average Price/OCF ratio for Charles River Laboratories International, Inc. (CRL)?

The 3Y average Price/OCF ratio for CRL stock is 13.54.

What is the 5Y average Price/OCF ratio for Charles River Laboratories International, Inc. (CRL)?

The 5Y average Price/OCF ratio for CRL stock is 15.26.

What is the 10Y average Price/OCF ratio for Charles River Laboratories International, Inc. (CRL)?

The 10Y average Price/OCF ratio for CRL stock is 15.63.

What is the 15Y average Price/OCF ratio for Charles River Laboratories International, Inc. (CRL)?

The 15Y average Price/OCF ratio for CRL stock is 14.11.

What is the 20Y average Price/OCF ratio for Charles River Laboratories International, Inc. (CRL)?

The 20Y average Price/OCF ratio for CRL stock is 13.82.

DATE	PRICE/OCF RATIO
2026-09-02	24.30
2026-09-01	23.52
2026-08-31	24.01
2026-08-28	24.28
2026-08-27	24.69
2026-08-26	24.58
2026-08-25	24.79
2026-08-24	24.87
2026-08-21	24.59
2026-08-20	24.27
2026-08-19	24.15
2026-08-18	23.25
2026-08-17	23.87
2026-08-14	23.32
2026-08-13	23.43
2026-08-12	23.68
2026-08-11	23.49
2026-08-10	23.07
2026-08-07	22.28
2026-08-06	22.11
2026-08-05	21.71
2026-08-04	18.88
2026-08-03	18.62
2026-07-31	18.75
2026-07-30	18.92
2026-07-29	18.93
2026-07-28	19.39
2026-07-27	18.09
2026-07-24	18.27
2026-07-23	18.49
2026-07-22	17.64
2026-07-21	17.69
2026-07-20	17.72
2026-07-17	18.09
2026-07-16	18.48
2026-07-15	18.40
2026-07-14	18.64
2026-07-13	18.53
2026-07-10	18.82
2026-07-09	18.84
2026-07-08	18.06
2026-07-07	18.44
2026-07-06	18.66
2026-07-02	18.60
2026-07-01	18.47
2026-06-30	18.29
2026-06-29	18.19
2026-06-26	17.40
2026-06-25	17.15
2026-06-24	16.30
2026-06-23	15.05
2026-06-22	14.64
2026-06-18	14.92
2026-06-17	14.70
2026-06-16	14.90
2026-06-15	15.20
2026-06-12	15.12
2026-06-11	15.17
2026-06-10	15.02
2026-06-09	15.31
2026-06-08	15.03
2026-06-05	14.62
2026-06-04	14.98
2026-06-03	14.50
2026-06-02	14.10
2026-06-01	14.68
2026-05-29	14.57
2026-05-28	14.62
2026-05-27	13.26
2026-05-26	12.64
2026-05-22	12.93
2026-05-21	12.81
2026-05-20	12.58
2026-05-19	12.29
2026-05-18	12.09
2026-05-15	12.16
2026-05-14	12.83
2026-05-13	13.13
2026-05-12	13.60
2026-05-11	13.58
2026-05-08	14.32
2026-05-07	14.65
2026-05-06	12.13
2026-05-05	12.37
2026-05-04	11.50
2026-05-01	11.06
2026-04-30	11.14
2026-04-29	10.93
2026-04-28	11.13
2026-04-27	11.42
2026-04-24	11.33
2026-04-23	11.19
2026-04-22	12.33
2026-04-21	12.22
2026-04-20	12.38
2026-04-17	12.27
2026-04-16	11.81
2026-04-15	12.05
2026-04-14	11.96
2026-04-13	11.90
2026-04-10	11.72
2026-04-09	11.71
2026-04-08	11.68
2026-04-07	11.31
2026-04-06	11.22
2026-04-02	11.60
2026-04-01	11.67
2026-03-31	11.51
2026-03-30	10.66
2026-03-27	10.62
2026-03-26	11.02
2026-03-25	11.07
2026-03-24	10.62
2026-03-23	10.54
2026-03-20	10.25
2026-03-19	10.21
2026-03-18	10.48
2026-03-17	10.26
2026-03-16	10.14
2026-03-13	10.37
2026-03-12	10.19
2026-03-11	11.27
2026-03-10	11.17
2026-03-09	11.81
2026-03-06	11.64
2026-03-05	12.10
2026-03-04	11.98
2026-03-03	11.72
2026-03-02	11.92
2026-02-27	11.91
2026-02-26	11.71
2026-02-25	11.18
2026-02-24	11.08
2026-02-23	10.91
2026-02-20	11.27
2026-02-19	10.96
2026-02-18	10.54
2026-02-17	10.45
2026-02-13	10.64
2026-02-12	10.47
2026-02-11	10.95
2026-02-10	11.95
2026-02-09	12.25
2026-02-06	12.48
2026-02-05	12.11
2026-02-04	13.30
2026-02-03	13.28
2026-02-02	14.06
2026-01-30	13.88
2026-01-29	13.96
2026-01-28	14.30
2026-01-27	14.48
2026-01-26	14.66
2026-01-23	14.48
2026-01-22	14.77
2026-01-21	14.95
2026-01-20	14.39
2026-01-16	14.49
2026-01-15	14.74
2026-01-14	14.27
2026-01-13	14.44
2026-01-12	14.43
2026-01-09	14.57
2026-01-08	14.21
2026-01-07	14.30
2026-01-06	14.25
2026-01-05	13.74
2026-01-02	13.35
2025-12-31	13.15
2025-12-30	13.32
2025-12-29	13.40
2025-12-26	13.43
2025-12-24	13.40
2025-12-23	13.38
2025-12-22	13.39
2025-12-19	13.00
2025-12-18	12.78
2025-12-17	12.92
2025-12-16	12.87
2025-12-15	13.07
2025-12-12	12.73
2025-12-11	12.82
2025-12-10	12.85
2025-12-09	12.27
2025-12-08	12.34
2025-12-05	12.15
2025-12-04	12.14
2025-12-03	12.18
2025-12-02	11.52
2025-12-01	11.61
2025-11-28	11.75
2025-11-26	11.80
2025-11-25	11.74
2025-11-24	11.24
2025-11-21	11.06
2025-11-20	10.69
2025-11-19	10.66
2025-11-18	10.72
2025-11-17	10.73
2025-11-14	11.07
2025-11-13	11.16
2025-11-12	11.31
2025-11-11	11.44
2025-11-10	11.14
2025-11-07	11.08
2025-11-06	11.27
2025-11-05	11.06
2025-11-04	11.14
2025-11-03	11.20
2025-10-31	11.28
2025-10-30	11.22
2025-10-29	11.28
2025-10-28	11.77
2025-10-27	12.23
2025-10-24	12.34
2025-10-23	11.96
2025-10-22	11.71
2025-10-21	11.79
2025-10-20	11.53
2025-10-17	11.18
2025-10-16	10.96
2025-10-15	10.69
2025-10-14	10.65
2025-10-13	10.69
2025-10-10	10.46
2025-10-09	10.78
2025-10-08	10.86
2025-10-07	10.65
2025-10-06	10.96
2025-10-03	11.11
2025-10-02	10.98
2025-10-01	10.68
2025-09-30	9.80
2025-09-29	9.21
2025-09-26	9.30
2025-09-25	9.12
2025-09-24	9.36
2025-09-23	9.41
2025-09-22	9.64
2025-09-19	9.73
2025-09-18	9.83
2025-09-17	9.56
2025-09-16	9.49
2025-09-15	9.53
2025-09-12	9.58
2025-09-11	10.00
2025-09-10	9.60
2025-09-09	9.86
2025-09-08	10.15
2025-09-05	10.27
2025-09-04	10.17
2025-09-03	10.17
2025-09-02	10.10
2025-08-29	10.23
2025-08-28	10.22
2025-08-27	10.20
2025-08-26	10.25
2025-08-25	10.28
2025-08-22	10.14
2025-08-21	9.68

DATE

PRICE/OCF RATIO

2026-09-02

24.30

2026-09-01

23.52

2026-08-31

24.01

2026-08-28

24.28

2026-08-27

24.69

2026-08-26

24.58

2026-08-25

24.79

2026-08-24

24.87

2026-08-21

24.59

2026-08-20

24.27

2026-08-19

24.15

2026-08-18

23.25

2026-08-17

23.87

2026-08-14

23.32

2026-08-13

23.43

2026-08-12

23.68

2026-08-11

23.49

2026-08-10

23.07

2026-08-07

22.28

2026-08-06

22.11

2026-08-05

21.71

2026-08-04

18.88

2026-08-03

18.62

2026-07-31

18.75

2026-07-30

18.92

2026-07-29

18.93

2026-07-28

19.39

2026-07-27

18.09

2026-07-24

18.27

2026-07-23

18.49

2026-07-22

17.64

2026-07-21

17.69

2026-07-20

17.72

2026-07-17

18.09

2026-07-16

18.48

2026-07-15

18.40

2026-07-14

18.64

2026-07-13

18.53

2026-07-10

18.82

2026-07-09

18.84

2026-07-08

18.06

2026-07-07

18.44

2026-07-06

18.66

2026-07-02

18.60

2026-07-01

18.47

2026-06-30

18.29

2026-06-29

18.19

2026-06-26

17.40

2026-06-25

17.15

2026-06-24

16.30

2026-06-23

15.05

2026-06-22

14.64

2026-06-18

14.92

2026-06-17

14.70

2026-06-16

14.90

2026-06-15

15.20

2026-06-12

15.12

2026-06-11

15.17

2026-06-10

15.02

2026-06-09

15.31

2026-06-08

15.03

2026-06-05

14.62

2026-06-04

14.98

2026-06-03

14.50

2026-06-02

14.10

2026-06-01

14.68

2026-05-29

14.57

2026-05-28

14.62

2026-05-27

13.26

2026-05-26

12.64

2026-05-22

12.93

2026-05-21

12.81

2026-05-20

12.58

2026-05-19

12.29

2026-05-18

12.09

2026-05-15

12.16

2026-05-14

12.83

2026-05-13

13.13

2026-05-12

13.60

2026-05-11

13.58

2026-05-08

14.32

2026-05-07

14.65

2026-05-06

12.13

2026-05-05

12.37

2026-05-04

11.50

2026-05-01

11.06

2026-04-30

11.14

2026-04-29

10.93

2026-04-28

11.13

2026-04-27

11.42

2026-04-24

11.33

2026-04-23

11.19

2026-04-22

12.33

2026-04-21

12.22

2026-04-20

12.38

2026-04-17

12.27

2026-04-16

11.81

2026-04-15

12.05

2026-04-14

11.96

2026-04-13

11.90

2026-04-10

11.72

2026-04-09

11.71

2026-04-08

11.68

2026-04-07

11.31

2026-04-06

11.22

2026-04-02

11.60

2026-04-01

11.67

2026-03-31

11.51

2026-03-30

10.66

2026-03-27

10.62

2026-03-26

11.02

2026-03-25

11.07

2026-03-24

10.62

2026-03-23

10.54

2026-03-20

10.25

2026-03-19

10.21

2026-03-18

10.48

2026-03-17

10.26

2026-03-16

10.14

2026-03-13

10.37

2026-03-12

10.19

2026-03-11

11.27

2026-03-10

11.17

2026-03-09

11.81

2026-03-06

11.64

2026-03-05

12.10

2026-03-04

11.98

2026-03-03

11.72

2026-03-02

11.92

2026-02-27

11.91

2026-02-26

11.71

2026-02-25

11.18

2026-02-24

11.08

2026-02-23

10.91

2026-02-20

11.27

2026-02-19

10.96

2026-02-18

10.54

2026-02-17

10.45

2026-02-13

10.64

2026-02-12

10.47

2026-02-11

10.95

2026-02-10

11.95

2026-02-09

12.25

2026-02-06

12.48

2026-02-05

12.11

2026-02-04

13.30

2026-02-03

13.28

2026-02-02

14.06

2026-01-30

13.88

2026-01-29

13.96

2026-01-28

14.30

2026-01-27

14.48

2026-01-26

14.66

2026-01-23

14.48

2026-01-22

14.77

2026-01-21

14.95

2026-01-20

14.39

2026-01-16

14.49

2026-01-15

14.74

2026-01-14

14.27

2026-01-13

14.44

2026-01-12

14.43

2026-01-09

14.57

2026-01-08

14.21

2026-01-07

14.30

2026-01-06

14.25

2026-01-05

13.74

2026-01-02

13.35

2025-12-31

13.15

2025-12-30

13.32

2025-12-29

13.40

2025-12-26

13.43

2025-12-24

13.40

2025-12-23

13.38

2025-12-22

13.39

2025-12-19

13.00

2025-12-18

12.78

2025-12-17

12.92

2025-12-16

12.87

2025-12-15

13.07

2025-12-12

12.73

2025-12-11

12.82

2025-12-10

12.85

2025-12-09

12.27

2025-12-08

12.34

2025-12-05

12.15

2025-12-04

12.14

2025-12-03

12.18

2025-12-02

11.52

2025-12-01

11.61

2025-11-28

11.75

2025-11-26

11.80

2025-11-25

11.74

2025-11-24

11.24

2025-11-21

11.06

2025-11-20

10.69

2025-11-19

10.66

2025-11-18

10.72

2025-11-17

10.73

2025-11-14

11.07

2025-11-13

11.16

2025-11-12

11.31

2025-11-11

11.44

2025-11-10

11.14

2025-11-07

11.08

2025-11-06

11.27

2025-11-05

11.06

2025-11-04

11.14

2025-11-03

11.20

2025-10-31

11.28

2025-10-30

11.22

2025-10-29

11.28

2025-10-28

11.77

2025-10-27

12.23

2025-10-24

12.34

2025-10-23

11.96

2025-10-22

11.71

2025-10-21

11.79

2025-10-20

11.53

2025-10-17

11.18

2025-10-16

10.96

2025-10-15

10.69

2025-10-14

10.65

2025-10-13

10.69

2025-10-10

10.46

2025-10-09

10.78

2025-10-08

10.86

2025-10-07

10.65

2025-10-06

10.96

2025-10-03

11.11

2025-10-02

10.98

2025-10-01

10.68

2025-09-30

9.80

2025-09-29

9.21

2025-09-26

9.30

2025-09-25

9.12

2025-09-24

9.36

2025-09-23

9.41

2025-09-22

9.64

2025-09-19

9.73

2025-09-18

9.83

2025-09-17

9.56

2025-09-16

9.49

2025-09-15

9.53

2025-09-12

9.58

2025-09-11

10.00

2025-09-10

9.60

2025-09-09

9.86

2025-09-08

10.15

2025-09-05

10.27

2025-09-04

10.17

2025-09-03

10.17

2025-09-02

10.10

2025-08-29

10.23

2025-08-28

10.22

2025-08-27

10.20

2025-08-26

10.25

2025-08-25

10.28

2025-08-22

10.14

2025-08-21

9.68

Price/OCF Ratio: 24.30

CRL Price/OCF Ratio Chart

CRL Average Price/OCF Ratio Chart

CRL Current vs Average Price/OCF Ratio Chart

CRL Price/OCF Ratio Metrics

CRL Competitors' Price/OCF Ratio

Operating Cash Flow Valuation

Price/OCF Ratio Formula & Definition

Price/OCF Ratio FAQ

CRL Price/OCF Ratio History

Related Metrics